Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001178913-24-003737
Filing Date
2024-11-15
Accepted
2024-11-15 16:05:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 zk2432348.htm 424B5 6868
2 image0.jpg GRAPHIC 367421
  Complete submission text file 0001178913-24-003737.txt   514043
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275002 | Film No.: 241467816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)